KingCreate Biotechnology Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2016

Location

Guangzhou Guangdong China

Primary Industry

Medical Devices & Equipment

About

Established in 2016 and based in Guangzhou, China, Yunjing operates as a biotechnology company that provides precision medical in vitro diagnostic products. The company cooperates with illumina, Nayo Lab and Henan Cancer Hospital, etc. It covers an area of about 3300 square feet and has over 2500 square feet of instrument production workshop, reagent production workshop, QC production workshop, testing laboratory and R&D laboratory. In April 2020, the company promoted the Desktop High-Throughput Sequencer with Illumina. In October 2021, it was awarded the title of "2021 Guangzhou Future Unicorn Innovative Enterprise". In August 2023, the company closed series C funding led by SJ Jiacheng Investment Management, with participation from Aurora Private Equity and Legend Capital. The company provides tNGS (targeted sequencing) technology platforms and molecular diagnostics solutions. Its product mainly includes medical devices, including KM MiniSeqDx-CN, liquid-based cell and lung cancer kit. And it has many clinical trial products, such as lung cancer rayon 11 gene organized version and colorectal cancer raytek 10 gene tissue version.

Current Investors

Legend Capital, China Development Bank Capital, Shiyu Capital

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Molecular Science, Genetics & Gene Therapy, Oncology/Cancer Treatment, Therapeutic Devices

Website

www.kingcreate.com.cn

Verticals

Manufacturing

Company Stage

Series C

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.